טוען...
Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
• Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF.
שמור ב:
| הוצא לאור ב: | Ann Med Surg (Lond) |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7251495/ https://ncbi.nlm.nih.gov/pubmed/32477499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amsu.2020.05.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|